ignificance of distinct specifically enriched missense TP53 mutations in prostate cancer

被引：0
|
作者：
Vasilevskaya, Irina [1 ]
McCann, Jennifer [1 ]
McNair, Christopher [1 ]
Neupane, Neermala Poudel [1 ]
Gallagher, Peter [1 ]
Knudsen, Karen E. [1 ]
机构：
[1] Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
377
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment
    Maddalena, Martino
    Mallel, Giuseppe
    Nataraj, Nishanth Belugali
    Shreberk-Shaked, Michal
    Hassin, Ori
    Mukherjee, Saptaparna
    Arandkar, Sharathchandra
    Rotkopf, Ron
    Kapsack, Abby
    Lambiase, Giuseppina
    Pellegrino, Bianca
    Ben-Isaac, Eyal
    Golani, Ofra
    Addadi, Yoseph
    Hajaj, Emma
    Eilam, Raya
    Straussman, Ravid
    Yarden, Yosef
    Lotem, Michal
    Oren, Moshe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (23)
  • [22] Limited importance of the dominant-negative effect of TP53 missense mutations
    Stoczynska-Fidelus, Ewelina
    Szybka, Malgorzata
    Piaskowski, Sylwester
    Bienkowski, Michal
    Hulas-Bigoszewska, Krystyna
    Banaszczyk, Mateusz
    Zawlik, Izabela
    Jesionek-Kupnicka, Dorota
    Kordek, Radzislaw
    Liberski, Pawel P.
    Rieske, Piotr
    BMC CANCER, 2011, 11
  • [23] Prostate cancer-specific enrichment of TP53 missense mutations elicits differential, context-dependent biochemical and biologic outcomes
    McCann, Jennifer J.
    Vasilevskaya, Irina
    PoudelNeupane, Neermala
    Dean, Jeffry
    Mandigo, Amy
    De Leeuw, Renee
    McNair, Chris
    Schiewer, Matthew
    Knudsen, Karen
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
    Zhou, Jie
    Lai, Yiming
    Peng, Shengmeng
    Tang, Chen
    Chen, Yongming
    Li, Lingfeng
    Huang, Hai
    Guo, Zhenghui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Are mutations of the TP53 tumour suppressor gene risk factors for prostate cancer formation?
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 183 - 183
  • [26] Immunohistochemical correlates of TP53 somatic mutations in cancer
    Murnyak, Balazs
    Hortobagyi, Tibor
    ONCOTARGET, 2016, 7 (40) : 64910 - 64920
  • [27] TP53 mutations in Romanian patients with colorectal cancer
    Felix Manirakiza
    Hidetaka Yamada
    Yuji Iwashita
    Keiko Ishino
    Rei Ishikawa
    Zsolt Kovacs
    Eva Osvath
    Augustin Nzitakera
    Simona Gurzu
    Haruhiko Sugimura
    Genes and Environment, 45
  • [28] HAEMATOLOGICAL CANCER TP53 mutations sensitize to decitabine
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (02) : 72 - 72
  • [29] The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
    Brachova, Pavla
    Thiel, Kristina W.
    Leslie, Kimberly K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 19257 - 19275
  • [30] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
12345